Fluvoxamine for Outpatient Management of COVID-19 to Prevent Hospitalization: A Systematic Review and Meta-analysis

IMPORTANCE: Widely available and affordable options for the outpatient management of COVID-19 are needed, particularly for therapies that prevent hospitalization. OBJECTIVE: To perform a meta-analysis of the available randomized clinical trial evidence for fluvoxamine in the outpatient management of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Todd C., Vigod, Simone, Bortolussi-Courval, Émilie, Hanula, Ryan, Boulware, David R., Lenze, Eric J., Reiersen, Angela M., McDonald, Emily G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987902/
https://www.ncbi.nlm.nih.gov/pubmed/35385087
http://dx.doi.org/10.1001/jamanetworkopen.2022.6269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987902/
https://www.ncbi.nlm.nih.gov/pubmed/35385087
http://dx.doi.org/10.1001/jamanetworkopen.2022.6269

Ejemplares similares